Recursion Pharmaceuticals, Inc. RXRX Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s intangibles (net)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported intangibles (net) of $294.07M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s intangibles (net) changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s intangibles (net) decreased by 12.4% year-over-year, from $335.79M to $294.07M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s intangibles (net)?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s intangibles (net) has grown at a 183.6% compound annual growth rate (CAGR), from $1.69M to $309.9M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.